In this interview with eCancer, the CEO of the Nigeria Sovereign Investment Authority (NSIA), Aminu Umar-Sadiq, discusses the work of NSIA with building new cancer centers in Nigeria. Watch the video here.
Category Archives: Nigeria
Two-day lecture series teaches African care providers best practices in cancer pain management
More than 80% of all cancer patients in Africa present to their local health facility with advanced disease. As cancer progresses into later disease stages, it is frequently accompanied by pain caused by the tumor’s disruption of normal tissue processes. Despite the significant burden of advanced disease, as described in the 2022 Lancet Oncology CommissionContinue reading “Two-day lecture series teaches African care providers best practices in cancer pain management”
Nigerian radiation oncology center launches advanced radiotherapy service
Based in Lagos, Nigeria, the NSIA-LUTH Cancer Center (NLCC) is one of three Nigerian facilities offering radiation therapy. Funded by the Nigerian Sovereign Investment Authority (NSIA), NLCC is built upon a foundation of partnership and is committed to offering cancer patients cutting-edge care. The center, which opened in 2019, has treated more than 5,000 cancerContinue reading “Nigerian radiation oncology center launches advanced radiotherapy service”
Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians
Africa has historically been overlooked by the international oncology research community, resulting in the continent’s participation in less than 2% of all cancer clinical trials. Africa’s underrepresentation in cancer clinical trials has culminated in an alarming lack of data describing the effects of new cancer technologies and treatments in the world’s most genetically diverse population.Continue reading “Clinical trial training program addresses cancer data gap in Africa and enables new research ventures for African clinicians”
AC3T Study Pool Mini-Grants empower early-career cancer researchers
Despite representing 4% of the world’s new cancer cases in 2020, only 0.5% of cancer clinical trials have been performed in sub-Saharan Africa. Several factors, including the continent’s limited number of experienced clinical researchers, have contributed to Africa’s underrepresentation in clinical trials. Given the continent’s predicted increase in new cancer cases over the next twoContinue reading “AC3T Study Pool Mini-Grants empower early-career cancer researchers”
Customized training programs lead to knowledge exchanges between US and African pathologists
Without intervention, experts predict that cancer mortality in sub-Saharan Africa will double to 1 million deaths per year by 2040. Accurate diagnoses by pathology professionals are essential to positive cancer treatment outcomes, yet most African countries – including Nigeria – face a shortage of routine training opportunities that are needed to hone the oncology skills ofContinue reading “Customized training programs lead to knowledge exchanges between US and African pathologists”
Nigeria’s Arise News Television Interview on AAI
(November 2019) – Jennifer Dent sits down with Nigeria’s Arise News for a live, prime-time broadcast interview to discuss how AAI is working to improve cancer patient outcomes in Africa. Watch here.